Galactosemia
What's New
Last Posted: Feb 01, 2024
- Incidental Detection of Classical Galactosemia through Newborn Screening for Phenylketonuria: A 10-Year Retrospective Audit to Determine the Efficacy of This Approach.
Nathan W P Cantley et al. Int J Neonatal Screen 2024 10(1) - Prospects for Expansion of Universal Newborn Screening in Bulgaria: A Survey among Medical Professionals.
Georgi Iskrov et al. Int J Neonatal Screen 2023 9(4) - The challenges of classical galactosemia: HRQoL in pediatric and adult patients.
Merel E Hermans et al. Orphanet J Rare Dis 2023 18(1) 135 - Secondary Reporting of G6PD Deficiency on Newborn Screening.
Stephanie C Hoang et al. Int J Neonatal Screen 9(2) - Association of genetic disorders and congenital malformations with premature ovarian insufficiency: a nationwide register-based study.
H Silvén et al. Human reproduction (Oxford, England) 2023 - The Importance of Neonatal Screening for Galactosemia.
Badiu Ti?a Ioana et al. Nutrients 2023 15(1) - Addition of Galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.
Daas Suha et al. Journal of inherited metabolic disease 2022 - All aspects of galactosemia: a single center experience.
Akgun Abdurrahman et al. Journal of pediatric endocrinology & metabolism : JPEM 2022 - Qualitative interviews with adults with Classic Galactosemia and their caregivers: disease burden and challenges with daily living.
Randall Jason A et al. Orphanet journal of rare diseases 2022 17(1) 138 - Neonatal screening program for five conditions in Honduras.
Buckley Michelle Melissa Miralda et al. Journal of community genetics 2021 Jan - NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study.
Singh Kanika et al. BMC medical genetics 2020 Nov 21(1) 216 - Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.
Mohamed Sarar et al. Saudi medical journal 2020 Jul 41(7) 703-708 - The Galactose Index measured in fibroblasts of GALT deficient patients distinguishes variant patients detected by newborn screening from patients with classical phenotypes.
Welsink-Karssies M M et al. Molecular genetics and metabolism 2020 Jan - Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Kommalur Anitha et al. Journal of tropical pediatrics 2019 Dec - Reducing complexity: explaining inborn errors of metabolism and their treatment to children and adolescents.
Zeltner Nina A et al. Orphanet journal of rare diseases 2019 Nov 14(1) 248 - Galactosemia.
Cerone Jennifer et al. Pediatrics in review 2019 Oct 40(Suppl 1) 24-27 - Web medical information produces anxiety in parents of infants with suspected galactosemia.
Iakovou Kostas et al. Reviews on environmental health 2019 Feb - Hereditary galactosemia.
Demirbas Didem et al. Metabolism: clinical and experimental 2018 83188-196 - Developmental Outcomes in Duarte Galactosemia.
Carlock Grace et al. Pediatrics 2018 Dec - Answering a Question Older Than Most Pediatricians: What to Do About Duarte Variant Galactosemia.
McCandless Shawn E et al. Pediatrics 2018 Dec
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2024
- Content source: